Is Alembic Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Alembic Pharmaceuticals pays dividends. Last time was Wednesday 21st of August 2024 where the investors holding the stock on Monday 15th of July 2024 were paid INR11 per share. Over the last 13 times between 2012 and 2024, Alembic Pharmaceuticals has paid INR73.9 with an average of INR5.68 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Alembic Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR497.70, you would have made a profit of INR608.00 per share or 122.16%
Yes, the average daily trading liquidity for Alembic Pharmaceuticals is INR431 680 thousand. You should therefore be able to get in and out of your positions relatively fast.
Alembic Pharmaceuticals has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.79, the company's ability to pay off the debt is good. Alembic Pharmaceuticals has a good net profit margin of 9.89% and should have high tolerances against inflation.
We have calculated the inflation risk for Alembic Pharmaceuticals to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.